No Data
Utah Medical Products' (NASDAQ:UTMD) Soft Earnings Don't Show The Whole Picture
Utah Medical Products | 10-Q: Q3 2024 Earnings Report
With 66% Institutional Ownership, Utah Medical Products, Inc. (NASDAQ:UTMD) Is a Favorite Amongst the Big Guns
Utah Medical Products GAAP EPS of $3.09, Revenue of $31.74M
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
Utah Beauty's same-store sales fell by 1.2% in the second quarter, falling short of analyst expectations.
On August 30th, Utah Beauty's same-store sales fell by 1.2%, while analysts expected growth of 1.32%. Net sales for the second quarter were $2.6 billion, with analysts expecting $2.61 billion. Net sales for the full year are expected to be $11 billion to $11.2 billion, compared to the company's original forecast of $11.5 billion to $11.6 billion. Same-store sales for the full year are expected to decline by 2% to zero growth, compared to the company's original expectation of 2%-3%, while analysts expect growth of 1.89%.
No Data
No Data